期刊文献+

纳米碳负显像结合^(99m)Tc-MIBI术中定位甲状旁腺的研究 被引量:7

Research for intraoperative localization of parathyroid gland using nanocarbon imaging combined with ^(99m)Tc-MIBI
原文传递
导出
摘要 目的:探索甲状旁腺功能亢进手术中运用纳米碳混悬液和低剂量^(99m)Tc-MIBI定位旁腺的临床应用。方法:将44例继发性肾性甲状旁腺功能亢进患者随机分为3组,即低剂量^(99m)Tc-MIBI+纳米碳(组Ⅰ)、高剂量^(99m) Tc-MIBI+纳米碳(组Ⅱ)、对照组(组Ⅲ)。比较其术前术后甲状旁腺激素(PTH)、血钙、术中甲状旁腺同位素放射量等实验数据。采用t检验和方差分析进行统计学处理。结果:术后PTH组Ⅰ为(23.8±32.4)ng/L,组Ⅱ为(15.8±18.2)ng/L,组Ⅲ为(90.1±139.4)ng/L,组Ⅰ与组Ⅱ均明显小于组Ⅲ,差异有统计学意义(P<0.05),组Ⅰ与组Ⅱ之间差异无统计学意义(P>0.05)。3组术中甲状旁腺的体内、体外放射量对比无明显差异。结论:纳米碳+^(99m)Tc-MIBI对继发性甲状旁腺手术有重要的定位价值,而低剂量的^(99m)Tc-MIBI可以减低患者的费用、降低辐射,同时可以达到相同的应用结果。 Objective:To explore the clinical application of nanocarbon(NC)suspension liquid combined with low dose of ^(99m)Tc-MIBI for parathyroid localization in the hyperparathyroidism surgery.Method:Forty-four patients with secondary hyperparathyroidism(SHPT)in the department of head-neck surgery of Renji Hospital,affiliated to Shanghai Jiaotong University,School of Medicine,were enrolled and randomized into 3groups including low-dose ^(99m)Tc-MIBI+ NC group Ⅰ,high-dose ^(99m)Tc-MIBI+ NC group Ⅱ,and control group Ⅲ.We compared the level of PTH,serum calcium before and after operation,and the intraoperative amount of radioactive isotopes of parathyroid gland,etc.Use t-test and Anova for statistical processing.Result:After operation,the PTH levels in group Ⅰ,Ⅱ,Ⅲ were(23.8±32.4)ng/L,(15.8±18.2)ng/L,(90.1±139.4)ng/L,respectively(groupⅠ vsⅢ,P〈0.05;group Ⅱ vsⅢ,P〈0.05,group Ⅰ vsⅡ,P〉0.05).The intraoperative amount of radioactive isotopes of parathyroid gland had no significant difference among groupⅠ,groupⅡand groupⅢ.Conclusion:Nanocarbon combined with ^(99m)Tc-MIBI for SHPT surgery has important localization value.And low dose of 99 mTcMIBI can reduce the cost and radiation,which can achieve the same outcome for patients.
出处 《临床耳鼻咽喉头颈外科杂志》 CAS 北大核心 2016年第18期1463-1466,共4页 Journal of Clinical Otorhinolaryngology Head And Neck Surgery
基金 仁济医院种子基金(No:RJZZ15-024)
关键词 99MTC-MIBI 甲状旁腺功能亢进 甲状旁腺定位 低剂量 纳米碳 99mTc-MIBI hyperparathyroidism localization low dose nanocarbon
  • 相关文献

参考文献13

  • 1SLATOPOLSKY E,BOWN A,DUSSO A.Role of phosphorus in pathogenesis of secondary hyperparathyroidism[J].Am J Kidney Dis,2001,37:S54-S57.
  • 2孙鲁英,王梅,杨莉.终末期肾脏病患者钙磷代谢及甲状旁腺激素水平的临床分析[J].北京大学学报(医学版),2005,37(2):147-150. 被引量:63
  • 3AGHA A.Recurrence of secondary hyperparathyroidism in patients after total parathyroidectomy with autotransplantation:technical and therapeutic aspects[J].Eur Arch Otorhinolaryngol,2012,269:1519-1525.
  • 4MURPHY C,NORMAN J.The 20%rule:a simple,instantaneous radioactivity measurement defines cure and allows elimination of frozen sections and hormone assays during parathyroidectomy[J].Surgery,1999,126:1023-1028.
  • 5GOLDSTEIN R E,BILLHEIMER D,MARTIN W H,et al.Sestamibi scanning and minimally invasive radioguidedparathyroidectomy without intraoperative parathyroid hormone measurement[J].Ann Surg,2003,237:722-730.
  • 6RUBELLO D,GIANNINI S,MARTINI C,et al.Minimally invasive radio-guided parathyroidectomy[J].Biomed Pharmacother,2006,60:134-138.
  • 7CAYO A,CHEN H.Radioguided reoperative parathyroidectomy for persistent primary hyperparathyroidism[J].Clin Nucl Med,2008,33:668-670.
  • 8FUJII T,YAJIMA R,YAMAGUCHI S,et al.Could the eZ-SCOPE AN gamma camera replace intraoperative measurement of iPTH for PHPT[J]?Int Surg,2012,97:99-103.
  • 9FERRETTI A,CHONDROGIANNIS S,MARCOLONGO A,et al.Phantom study of a new hand-heldγ-imaging probe for radio-guided surgery[J].Nucl Med Commun,2013,34:86-90.
  • 10CHEN J,ZHOU Q Y,WANG J D.Comparison between subtotal parathyroidectomy and total parathyroidectomy with autotransplantation for secondary hyperparathyroidism in patients with chronic renal failure:a meta-analysis[J].Horm Metab Res,2015,47:643-651.

二级参考文献28

  • 1Lemann JJ, Litzow JR, Lennon EJ. The effect of chronic acid loads in normal man: Further evidence against chronic metabolic acidosis[J]. J Clin Invest, 1966, 45:1608-1614
  • 2Lemann JJ, Litzow JR, Lennon EJ. Studies of the mechanism by which chronic metabolic acidosis augment urinary calcium excretion in man[J]. J Clin Invest, 1967, 46:1318-1328
  • 3Craig BL. Calcitriol metabolism during chronic metabolic acidosis[J]. Semin Nephrol, 1989, 9:65-71
  • 4Kurz P, Monier Faugere MC, Bognar B, et al. Evidence for abnormal calcium homeostasis in patients with adynamic bone disease[J]. Kidney Int, 1994, 46:855-861
  • 5Nakano Y, Oshima T, Sasaki S, et al. Vitamin D receptor gene polymorphism is associated with serum total and ionized calcium concentration[J]. J Mol Med, 2000, 78:575-579
  • 6Block GA, Hulbert-Shearon TE, Levin NW, et al. Association of serum phosphorus and calciumХphosphorus product with mortality risk in chronic hemodialysis patients: a national study[J]. Am J Kidney Dis, 1998, 31: 607-617
  • 7Amann K, Gross ML, London GM, et al. Hyperphosphataemia-a silent killer of patients with renal failure[J]? Nephrol Dial Transplant, 1999, 14:2085-2087
  • 8Brenner BM. The Kidney[M]. 北京: 科学出版社,2001. 520-556
  • 9Goldfarb S. Renal osteodystrophy, disorders of divalent ion metabolism, and nephrolithiasis[J]. Nephrology Self-Assessment Program, 2002, 1: 55-68
  • 10Cannata-Andia JB. Pathogenesis, prevention and management of low-bone turnover[J]. Nephrol Dial Transplant, 2000, 15(Suppl 5): 15-17

共引文献73

同被引文献74

引证文献7

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部